人工智能驱动的算法用于预测COVID-19后急性COVID-19患者对皮质类固醇治疗的反应
Vojtech Myska1, Samuel Genzor2, Anzhelika Mezina1
1Department of Telecommunications, Faculty of Electrical Engineering and Communications, Brno University of Technology, Technicka 12, 616 00 Brno, Czech Republic.
Diagnostics (Basel, Switzerland)
|May 27, 2023
概括
预测COVID-19肺纤维化患者的皮质疗法的益处至关重要. 机器学习模型可以识别可能通过类固醇治疗恢复的个体,帮助COVID-19后肺部并发症的个性化医疗.
科学领域:
- 医学研究 医学研究
- 人工智能在医学中的应用
- 肺部病理学 肺部病理学
背景情况:
- 肺纤维化是COVID-19的一种严重的长期并发症.
- 皮质类固醇治疗可以改善恢复,但存在风险.
- 需要个性化的治疗选择,以优化皮质疗法的结果.
研究的目的:
- 开发和评估机器学习模型,以预测COVID-19后皮质疗法对患者的益处.
- 为管理COVID-19相关的肺纤维化提供个性化治疗决策.
主要方法:
- 使用了多个机器学习算法 (逻辑回归,k-NN,决策树,XGBoost,随机森林,SVM,MLP,AdaBoost,LGBM).
- 在281名患者的数据上训练模型,包括体检,血液检查,肺功能检查和成像 (X射线,HRCT) 在基线和治疗后3个月.
- 使用诸如平衡精度 (BA),ROC-AUC和F1分数等指标评估模型性能.
主要成果:
- 决策树模型表现出强的表现,BA为73.52%,ROC-AUC为74.69%,F1得分为71.70%.
- 随机森林和AdaBoost也显示出具有竞争力的结果,表明了这些算法的潜力.
- 该研究证实,早期COVID-19后的治疗数据可以预测皮质疗法反应.
结论:
- 机器学习模型可以有效地预测哪些COVID-19相关的肺纤维化患者将从皮质疗法中受益.
- 这些预测工具可以帮助临床医生做出个性化治疗决策.
- 早期干预和数据分析是优化COVID-19后护理患者结果的关键.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
256
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
256
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
319
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
319
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
161
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
161
Asthma: Pathogenesis and Management
467
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
467
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K


